Accolade, Inc. (ACCD) Financials

ACCD Assets vs Liabilities

DateAssetsLiabilities
2024-02-29 788.2 million 342.7 million
2023-11-30 785.5 million 350.8 million
2023-08-31 854.3 million 416.7 million
2023-05-31 875.7 million 421.5 million

ACCD Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-02-29 3.8 million 15.3 million
2023-11-30 1.5 million 15.6 million
2023-08-31 -11.3 million 15.7 million
2023-05-31 -22.7 million 14.3 million

ACCD Net Income

No data available :(

ACCD Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-02-29 237.0 million - 32.7 million
2023-11-30 230.0 million - 33.5 million
2023-08-31 292.2 million - 30.6 million
2023-05-31 302.9 million - 32.7 million

ACCD Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-02-29 77.4 million
2023-11-30 76.1 million
2023-08-31 75.5 million
2023-05-31 73.2 million

ACCD Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-02-29 2.1 million 24.2 million 14.3 million 24.7 million
2023-11-30 3.7 million 23.5 million 15.5 million 26.2 million
2023-08-31 3.3 million 25.6 million 16.3 million 24.1 million
2023-05-31 3.4 million 25.9 million 16.1 million 25.0 million

ACCD Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-02-29 124.8 million 70.5 million
2023-11-30 99.4 million 54.5 million
2023-08-31 96.9 million 55.3 million
2023-05-31 93.2 million 54.2 million

ACCD

Price: $7.12

52 week price:
6.33
17.01

Earnings Per Share: -1.62 USD

P/E Ratio: -8.02

Exchange: NMS

Sector: Healthcare

Industry: Health Information Services

Volume: 1.5 million

Market Capitalization: 597.9 million

Links: